[go: up one dir, main page]

WO2019004984A3 - A pharmaceutical formulation comprising cholecalciferol - Google Patents

A pharmaceutical formulation comprising cholecalciferol Download PDF

Info

Publication number
WO2019004984A3
WO2019004984A3 PCT/TR2018/050236 TR2018050236W WO2019004984A3 WO 2019004984 A3 WO2019004984 A3 WO 2019004984A3 TR 2018050236 W TR2018050236 W TR 2018050236W WO 2019004984 A3 WO2019004984 A3 WO 2019004984A3
Authority
WO
WIPO (PCT)
Prior art keywords
cholecalciferol
pharmaceutical formulation
excipient
vitamin
source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2018/050236
Other languages
French (fr)
Other versions
WO2019004984A2 (en
Inventor
Umit Cifter
Urun Kandemirer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biofarma Ilac Sanayi ve Ticaret AS
Original Assignee
Biofarma Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofarma Ilac Sanayi ve Ticaret AS filed Critical Biofarma Ilac Sanayi ve Ticaret AS
Publication of WO2019004984A2 publication Critical patent/WO2019004984A2/en
Publication of WO2019004984A3 publication Critical patent/WO2019004984A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne une formulation pharmaceutique sous forme de comprimés à mâcher, comprenant un agent actif cholécalciférol de l'ordre de 600 IU à 3000 IU comme source de vitamine D3 et au moins un excipient dans un comprimé unitaire.The invention relates to a pharmaceutical formulation in the form of chewable tablets, comprising a cholecalciferol active agent of the order of 600 IU to 3000 IU as a source of vitamin D3 and at least one excipient in a unit tablet.

PCT/TR2018/050236 2017-05-29 2018-05-16 A pharmaceutical formulation comprising cholecalciferol Ceased WO2019004984A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2017/07762 2017-05-29
TR201707762 2017-05-29

Publications (2)

Publication Number Publication Date
WO2019004984A2 WO2019004984A2 (en) 2019-01-03
WO2019004984A3 true WO2019004984A3 (en) 2019-03-07

Family

ID=64741744

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/050236 Ceased WO2019004984A2 (en) 2017-05-29 2018-05-16 A pharmaceutical formulation comprising cholecalciferol

Country Status (1)

Country Link
WO (1) WO2019004984A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900014550A1 (en) * 2019-08-09 2021-02-09 Abiogen Pharma Spa USE OF CHOLECALCIFEROL AS AN ACTIVE AGENT IN THE TREATMENT OF CELIACIA

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003055500A1 (en) * 2002-01-04 2003-07-10 Italfarmaco, S.A. Pharmaceutical compositions for the treatment or prevention of osteoporosis
US20090041860A1 (en) * 2004-10-25 2009-02-12 Italfarmaco, S.A. Orally-dispersible pharmaceutical compositions
US20110130370A1 (en) * 2009-11-27 2011-06-02 Les Laboratories Servier Pharmaceutical composition comprising a strontium salt, vitamin D and A cyclodextrin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003055500A1 (en) * 2002-01-04 2003-07-10 Italfarmaco, S.A. Pharmaceutical compositions for the treatment or prevention of osteoporosis
US20090041860A1 (en) * 2004-10-25 2009-02-12 Italfarmaco, S.A. Orally-dispersible pharmaceutical compositions
US20110130370A1 (en) * 2009-11-27 2011-06-02 Les Laboratories Servier Pharmaceutical composition comprising a strontium salt, vitamin D and A cyclodextrin

Also Published As

Publication number Publication date
WO2019004984A2 (en) 2019-01-03

Similar Documents

Publication Publication Date Title
NO20080220L (en) Formulations with high drug loading and dosage forms
MA38399A1 (en) Formulation in tablet form, useful for treating acute heart failure and chronic heart failure
EP3600563C0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING VITAMIN D3 AND HYALURONIC ACID
NZ586588A (en) Formulation of ( follice stimulating hormone) fsh and varients with benzalkonium chloride and benzyl alcohol
BR112017024517A2 (en) tetrahydroquinolinone compounds as gamma modulators
WO2017037594A3 (en) Pharmaceutical composition used for reducing localised fat and use of pharmaceutical composition
FR3058059B1 (en) PHARMACEUTICAL COMPOSITION COMPRISING BETA-ELEMENE, LUPEOL AND 2-HYDROXYCINNAMALDEHYDE AND / OR 2'-BENZOYLOXYCINNALMALDEHYDE AND / OR BETA-SITOSTEROL AND / OR CURCUMIN.
WO2017083266A8 (en) Novel formulations
FR3065371B1 (en) TOPICAL PHARMACEUTICAL COMPOSITION INCLUDING AT LEAST AMITRIPTYLINE FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN
PH12017502322B1 (en) Therapeutic agent for fibrosis
CL2024001052A1 (en) Erdafitinib formulations and systems for intravesical administration.
MXPA06011467A (en) Active substance combination comprising a carbinol combined to at least an nsaid.
WO2019004984A3 (en) A pharmaceutical formulation comprising cholecalciferol
AU2020268767B8 (en) Liquid oral dosage formulations of methylnaltrexone
WO2020139237A3 (en) A bilayer tablet formulation of atorvastatin calcium and ezetimibe
BRPI0700133A (en) pharmaceutical composition comprising tramadol and ketoprofen in combination
MA46778A1 (en) Intranasal composition comprising betahistine
FR2887150B1 (en) PHARMACEUTICAL COMPOSITION COMPRISING AN ORGANOPOLYSILOXANE ELASTOMER AND A SOLUBILIZED ACTIVE INGREDIENT
EP4364810A3 (en) Topical formulations and uses thereof
WO2019059868A3 (en) Pharmaceutical combinations comprising tenofovir, emtricitabine and efavirenz
CR20170585A (en) PRODUCTION LINE FOR THE PRODUCTION OF MEDICINES AND PRODUCTION PLANT THAT INCLUDES A SUCH PRODUCTION LINE
BR112018012616A2 (en) galenic formulation comprising a topical drug
FR3058060B1 (en) PHARMACEUTICAL COMPOSITION COMPRISING BETA-ELEMENE, LUPEOL, CINNAMALDEHYDE AND / OR 2-HYDROXYCINNAMALDEHYDE AND / OR 2'-BENZOYLOXYCINNALMALDEHYDE AND / OR BETA-SITOSTEROL AND / OR CURCUMIN.
JOP20180128A1 (en) Orally-dispersible solid pharmaceutical formulation
MY162768A (en) Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18825276

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18825276

Country of ref document: EP

Kind code of ref document: A2